Device Trial Radar · NCT05506215
Randomized Clinical Study Comparing SynPath to Standard of Care in Treatment of Chronic Diabetic Foot Ulcers
Last checked: Nov 20, 2026Latest source record: Mar 5, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
25
Actual
Start
Jul 10, 2022
Primary completion
Feb 26, 2024
Study completion Feb 26, 2024
Sponsor
- Lead sponsor
- PolyNovo Biomaterials Pty Ltd.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 18, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study will evaluate the efficacy of SynPath™, a synthetic dermal matrix, in the treatment of diabetic foot ulcers in subjects with diabetes mellitus versus Standard of Care treatment. Half the subjects with be treated using SynPath™ while the other half will receive Standard of Care treatment
Conditions
- Diabetic Foot
- Chronic Foot Ulcer
- Wound Healing
- Foot Ulcer
Interventions
SynPath Acellular Dermal Matrix plus Off-loading DeviceDevice
Application of SynPath
Wound Dressing composed of 90% collagen and 10% Alginate plus Off-loading DeviceDevice
Application Wound Dressing composed of Collagen and Alginate
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of ulcer closed at 12 weeksTime frame: 12 weeks
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Center for Clinical Research
Castro Valley, California
Limb Preservation Platform, Inc
Fresno, California
ILD Research Center
Vista, California
4 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.